SAA1 alleles as risk factors in reactive systemic AA amyloidosis

Amyloid

Volumn 5, Issue 4, 1998, Pages 262-265

  Booth, David R ^a   Booth, Susanne E ^a   Gillmore, Julian D ^a   Hawkins, Philip N ^a   Pepys, Mark B ^a  

^a HAMMERSMITH HOSPITAL   (United Kingdom)

Author keywords

AA amyloidosis; Risk factor; SAA alleles; Serum amyloid A protein

Indexed keywords

PRIMER DNA; SERUM AMYLOID A;

ADULT; ALLELE; AMYLOIDOSIS; ARTICLE; CASE CONTROL STUDY; COHORT ANALYSIS; GENETICS; GENOTYPE; HUMAN; MALE; NUCLEOTIDE SEQUENCE; RISK FACTOR;

ADULT; ALLELES; AMYLOIDOSIS; BASE SEQUENCE; CASE-CONTROL STUDIES; COHORT STUDIES; DNA PRIMERS; GENOTYPE; HUMANS; MALE; RISK FACTORS; SERUM AMYLOID A PROTEIN;

EID: 0032241634     PISSN: 13506129     EISSN: None     Source Type: Journal    
DOI: 10.3109/13506129809007299     Document Type: Article

References (17)

1. Pepys MB (1994). Amyloidosis. In Frank MM, Austen KF, Claman HN and Unanue ER (eds). Samter's Immunologic Diseases, Fifth Ed., pp. 637-655. (Boston: Little, Brown and Company)
2. Benditt EP and Eriksen N (1977). Amyloid protein SAA is associated with high density lipoprotein from human serum. Proc Natl Acad Sci USA 74, 4025-4028
3. Sellar GC, Jordan SA, Bickmore WA, Fantes JA, van Heyningen V and Whitehead AS (1994). The human serum amyloid A protein (SAA) superfamily gene cluster: mapping to chromosome 11p15.1 by physical and genetic linkage analysis. Genomics 19, 221-227
4. 1 alleles. Amyloid: Int J Exp Clin Invest 1, 255-262
5. Liepnieks JJ, Kluve-Beckerman B and Benson MD (1995). Characterization of amyloid A protein in human secondary amyloidosis: the predominant deposition of serum amyloid Al. Biochim Biophys Acta 1270, 81-86
6. Baba S, Masago SA, Takahashi T, Kasama T, Sugimura H, Tsugane S, Tsutsui Y and Shirasawa H (1995). A novel allelic variant of serum amyloid A, SAA1γ: genomic evidence, evolution, frequency, and implication as a risk factor for reactive systemic AA-amyloidosis. Hum Med Genet 4, 1083-1087
7. 2-terminal sequence identity with only one of two serum amyloid protein (ApoSAA) gene products. J Exp Med 159, 641-646
8. Hawkins PN, Richardson S, Vigushin DM, David J, Kelsey CR, Gray RES, Hall MA, Woo P, Lavender JP and Pepys MB (1993). Serum amyloid P component scintigraphy and turnover studies for diagnosis and quantitative monitoring of AA amyloidosis in juvenile rheumatoid arthritis. Arthritis Rheum 36, 842-851
9. Hawkins PN (1994). Studies with radiolabelled serum amyloid P component provide evidence for turnover and regression of amyloid deposits in vivo. Clin Sci 87, 289-295
10. Tan SY, Pepys MB and Hawkins PN (1995). Treatment of amyloidosis. Am J Kidney Dis 26, 267-285
11. 123I-labeled serum amyloid P component. N Engl J Med 323, 508-513
12. Furuya K, Yamaguchi E and Kawakami Y (1994). Angiotensin-converting enzyme (ACE) polymorphism and serum ACE activities in sarcoidosis. Nippon-Rinsho 52, 1561-1566
13. Iso H, Folsom AR, Winkelmann JC, Koike K, Harada S, Greenberg B, Sato S, Shimamoto T, Lida M and Komachi Y (1995). Polymorphisms of the beta fibrinogen gene and plasma fibrinogen concentration in Caucasian and Japanese population samples. Thromb Haemostas 73, 106-111
14. Maury CPJ, Kere J, Tolvanen R and de la Chapelle A (1993). Homozygosity for Finnish type familial amyloidosis is associated with severe nephropathy. J Rheumatol 20, 191
15. Jacobson DR, Gorevic PD, Sack GH and Malamet RL (1993). Homozygous transthyretin His 58 associated with unusually aggressive familial amyloidotic polyneuropathy. J Rheumatol 20, 178
16. Windl O, Dempster M, Estibeiro JP, Lathe R, de Silva R, Esmonde T, Will R, Springbett A, Campbell TA, Sidle KC, Palmer MS and Collinge J (1996). Genetic basis of Creutzfeldt-Jakob disease in the United Kingdom: a systematic analysis of predisposing mutations and allelic variation in the PRNP gene. Hum Genet 98, 259-264
17. Yamada T, Kluve-Beckerman B, Liepnieks JJ and Benson MD (1994). Fibril formation from recombinant human serum amyloid A. Biochim Biophys Acta 1226, 323-329